تداخلهای دارویی
Indacaterol-glycopyrronium + Revefenacin
شدت: شدید
Indacaterol-glycopyrronium and Revefenacin: major interaction.
آخرین بهروزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصهای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمیشود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Revefenacin is an inhaled long-acting muscarinic antagonist, as is glycopyrronium, so the two duplicate anticholinergic therapy. Combined use may increase dry mouth, urinary retention, constipation, glaucoma risk and tachycardia.
معنای این تداخل به زبان ساده
Indacaterol-glycopyrronium and Revefenacin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Indacaterol-glycopyrronium belongs to Respiratory; Revefenacin belongs to Respiratory.
چرا رخ میدهد
Additive antimuscarinic effects from two long-acting muscarinic antagonists.
اقدام لازم
Avoid using two long-acting anticholinergics together and pick a single LAMA-containing regimen. Monitor for anticholinergic effects if the overlap occurs during a switch.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیههای کامل مدیریت Indacaterol-glycopyrronium و Revefenacin، یادداشتهای تکمیلی، جزئیات شواهد و بررسیکننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Indacaterol-glycopyrronium
تداخلات دیگر Revefenacin
پرسشهای متداول
Can I take Indacaterol-glycopyrronium with Revefenacin?
MediHelp rates the interaction as major. Indacaterol-glycopyrronium and Revefenacin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Revefenacin is an inhaled long-acting muscarinic antagonist, as is glycopyrronium, so the two duplicate anticholinergic therapy. Combined use may increase dry mouth, urinary retention, constipation, glaucoma risk and tachycardia.
How serious is the interaction between Indacaterol-glycopyrronium and Revefenacin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid using two long-acting anticholinergics together and pick a single LAMA-containing regimen. Monitor for anticholinergic effects if the overlap occurs during a switch.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
تکنگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.